SpringWorks Therapeutics, Inc.

Historical 13F Holders

Symbol
SWTX
CUSIP
85205L107
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 85205L107 since 12/18/2024, newest first.

Filer % of Class Filed
Goldman Sachs Group Inc 13G/A Amendment 1
0% 11/12/2025
Event 9/30/2025
Goldman Sachs Group Inc 13G
5.6% 8/13/2025
Event 6/30/2025
Hudson Bay Capital Management LP 13G
5.2% 8/8/2025
Event 6/30/2025
Glazer Capital, LLC 13G
0% 7/7/2025
Event 6/30/2025
FMR LLC 13G/A Amendment 5
1.7% 5/7/2025
Event 4/30/2025
Deep Track Capital, LP 13G/A Amendment 2
4.7% 2/14/2025
Event 12/31/2024
Vanguard Group Inc 13G/A Amendment 3 9.6% 1/31/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 1 1.00 $47.00
2026 Q1 1 1.00 $47.00
2025 Q4 2 40.0 k $2.18 M
2025 Q3 4 45.3 k $2.39 M
2025 Q2 260 78.5 M $3.69 B
2025 Q1 362 75.4 M $3.33 B
2024 Q4 232 80.9 M $2.92 B
2024 Q3 242 81.2 M $2.60 B
2024 Q2 226 79.9 M $3.01 B
2024 Q1 242 82.3 M $4.05 B
2023 Q4 196 77.0 M $2.81 B
2023 Q3 155 68.5 M $1.58 B
2023 Q2 151 69.6 M $1.82 B
2023 Q1 157 66.3 M $1.70 B
2022 Q4 152 70.3 M $1.83 B
2022 Q3 161 63.4 M $1.80 B
2022 Q2 156 55.9 M $1.38 B
2022 Q1 160 49.6 M $2.80 B
2021 Q4 151 50.3 M $3.12 B
2021 Q3 146 45.1 M $2.86 B
2021 Q2 139 49.7 M $4.10 B
2021 Q1 140 48.8 M $3.59 B
2020 Q4 127 43.4 M $3.15 B
2020 Q3 96 37.5 M $1.79 B
2020 Q2 79 34.8 M $1.46 B
2020 Q1 71 33.2 M $899 M
2019 Q4 59 32.1 M $1.24 B
2019 Q3 45 31.3 M $681 M
2019 Q2 1 53.9 k $4.45 M
2019 Q1 1 53.9 k $4.45 M